Association between prediagnostic symptoms and patterns of treatment initiation in people with Parkinson´s disease in the United Kingdom
Objective: To explore the association between prediagnostic symptoms and treatment initiation in people with Parkinson´s disease (PD) Background: Prediagnostic symptoms in people with PD may…Hospitalization causes and condition at discharge of Parkinson’s disease patients in Mexican public institutions between 2011 and 2017
Objective: Analyze the characteristics and clinical course of patients with Parkinson's disease hospitalized between 2011-2017. Background: Parkinson's disease (PD) is the most common neurodegenerative disease…Trends and Racial Disparities of Palliative Care Use among Hospitalized Patients with Parkinson’s Disease
Objective: To analyze the rate of palliative care consultations among hospitalized patients with Parkinson’s Disease (PD) using the National Inpatient Sample data from 2007 to…The relationship between REM sleep behavior disorder and cognitive impairment in drug-naïve Parkinson’s disease
Objective: We aim to compare the cognitive performances of drug-naïve PD patients who had RBD (PD-RBD) to PD patients without RBD (PD-NRBD) and healthy controls.…Predictors of different progressive trajectories of cognition in Parkinson’s disease
Objective: To identify subgroups of people living with Parkinson’s disease (PD) who have statistically distinct trajectories of Montreal Cognitive Assessment (MoCA) scores over four years,…Beta-Glucocerebrosidase Activity in GBA-linked Parkinson’s Disease: The Type of Mutation Matters
Objective: To test the relationship between clinically relevant types of GBA mutations (none, risk variants, mild mutations, severe mutations) and beta-glucocerebrosidase activity in patients with…A novel likely pathogenic SNCA variant associated with Parkinson’s disease
Objective: To report a novel SNCA likely pathogenic variant. Background: The A53T mutation in the SNCA gene, encoding alpha-synuclein (a-syn), was the first established genetic…GCH1 variants contribute to risk and earlier age at onset in Parkinson’s disease
Objective: Our aim was to identify the potential role of known genetic components of GCH1, including rare and common variants in coding and non-coding regions,…Diagnostic value of vagus nerve ultrasound in Parkinson’s disease
Objective: To detect by the ultrasound (US) the possible presence of vagus nerve atrophy in patients with PD and its relation to severity of motor,…Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson’s disease – a PET and MRI multi-modal imaging study
Objective: To assess multimodal imaging of the noradrenergic system: magnetic resonance imaging (MRI) neuromelanin contrast of the locus coeruleus (LC) and noradrenalin transporter density with…
- « Previous Page
- 1
- …
- 95
- 96
- 97
- 98
- 99
- …
- 388
- Next Page »